ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 183 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,122 | +18.2% | 219 | 0.0% | 0.00% | – |
| Q4 2022 | $3,486 | -75.1% | 219 | -61.2% | 0.00% | -100.0% |
| Q1 2022 | $14,000 | +7.7% | 564 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $13,000 | +85.7% | 564 | +28.5% | 0.00% | +100.0% |
| Q3 2021 | $7,000 | +16.7% | 439 | +86.0% | 0.00% | -66.7% |
| Q1 2021 | $6,000 | -25.0% | 236 | +57.3% | 0.00% | -25.0% |
| Q4 2020 | $8,000 | +33.3% | 150 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $6,000 | -50.0% | 150 | -40.0% | 0.00% | -60.0% |
| Q2 2020 | $12,000 | +9.1% | 250 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $11,000 | +22.2% | 250 | +25.0% | 0.01% | +66.7% |
| Q4 2019 | $9,000 | -18.2% | 200 | -33.3% | 0.00% | -40.0% |
| Q3 2019 | $11,000 | -31.2% | 300 | -50.0% | 0.01% | -28.6% |
| Q2 2019 | $16,000 | 0.0% | 600 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $16,000 | +60.0% | 600 | 0.0% | 0.01% | +40.0% |
| Q4 2018 | $10,000 | -41.2% | 600 | -25.7% | 0.01% | -28.6% |
| Q3 2018 | $17,000 | +6.2% | 807 | -21.0% | 0.01% | 0.0% |
| Q2 2018 | $16,000 | -52.9% | 1,021 | -31.9% | 0.01% | -56.2% |
| Q1 2018 | $34,000 | -35.8% | 1,500 | -14.3% | 0.02% | -30.4% |
| Q4 2017 | $53,000 | -11.7% | 1,750 | +9.4% | 0.02% | -20.7% |
| Q3 2017 | $60,000 | +27.7% | 1,600 | -5.9% | 0.03% | +20.8% |
| Q2 2017 | $47,000 | -16.1% | 1,700 | +5.1% | 0.02% | -17.2% |
| Q1 2017 | $56,000 | +19.1% | 1,618 | 0.0% | 0.03% | +16.0% |
| Q4 2016 | $47,000 | -2.1% | 1,618 | +6.6% | 0.02% | -3.8% |
| Q3 2016 | $48,000 | +6.7% | 1,518 | +8.4% | 0.03% | +4.0% |
| Q2 2016 | $45,000 | -2.2% | 1,400 | +7.7% | 0.02% | -3.8% |
| Q4 2015 | $46,000 | +7.0% | 1,300 | 0.0% | 0.03% | 0.0% |
| Q3 2015 | $43,000 | -17.3% | 1,300 | +4.0% | 0.03% | -13.3% |
| Q2 2015 | $52,000 | +26.8% | 1,250 | 0.0% | 0.03% | +15.4% |
| Q1 2015 | $41,000 | – | 1,250 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |